Clinical Trials Directory

Trials / Completed

CompletedNCT03548662

The Effect of Platelet Rich Plasma Injection Combined With Exercise Rehabilitation in Patients With Rotator Cuff Tear

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effect of platelet rich plasma combined with exercise therapy for patients with partial thickness rotator cuff tears.

Detailed description

The purpose of this study is to exam the outcome of rotator cuff tear patients who received platelet rich plasma injection followed by rehabilitative exercise. The specific aim of this study is to determine the outcomes of treatment of partial thickness rotator cuff tears with platelet rich plasma (PRP) and rehabilitative exercise. Subjects with partial thickness rotator cuff tears will be designated to receive an injection of PRP or hyaluronic acid, followed by rehabilitative exercise. Shoulder function and tendon healing will be evaluated using the patient surveys as well as ultrasound. Subjects will be followed for 3 months to determine the outcomes of the treatment. The hypothesis is that there is no difference in healing rate or functional outcomes in patients treated with PRP injections plus rehabilitative exercise compared with hyaluronic acid injection plus rehabilitative exercise for the treatment of partial thickness rotator cuff tears.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet-Rich PlasmaPlatelet-Rich Plasma prepared by RegenKit® PRP, Regenlab SA
DRUGHyaluronic AcidHyruan Plus Inj. produced by LG Life Sciences, Ltd.
OTHERExercisepassive range of motion (PROM) exercise, active-assisted range of motion (AAROM) exercise, active range of motion (AROM) exercise, rotator cuff strengthening exercise, and peri-scapular muscle strengthening exercise

Timeline

Start date
2014-03-04
Primary completion
2018-02-06
Completion
2018-02-06
First posted
2018-06-07
Last updated
2018-06-07

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03548662. Inclusion in this directory is not an endorsement.